News - dulaglutide


Current filters:


Popular Filters

More ADA highlights, from Eli Lilly on dulaglutide, J&J on Invokana and GSK on albiglutide


Continued news from the 73rd Scientific Sessions of the American Diabetes Association being held in Chicago,…

albiglutideDiabetesdulaglutideEli LillyGlaxoSmithKlineInvokanaJohnson & JohnsonLY605541PharmaceuticalResearch

Lilly's diabetes drug dulaglutide does well in two additional trials


US drug major Eli Lilly (NYSE: LLY) has released positive top-line results of two additional Phase III…

DiabetesdulaglutideEli LillyPharmaceuticalResearch

Lilly's dulaglutide beats three other diabetes drugs in lowering blood sugar levels


US pharma major Eli Lilly (NYSE: LLY) reported positive top-line results of three completed Phase III…

DiabetesdulaglutideEli LillyPharmaceuticalResearch

Back to top